ArticleRadiology and oncology2016
The dosimetric significance of using 10 MV photons for volumetric modulated arc therapy for post-prostatectomy irradiation of the prostate bed.
Article in Radiology and oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Review
- Correlation between patient-specific quality assurance in volumetric modulated arc therapy and 2D dose image features.Scientific reports · 2023Article
- Assessment of Radiation-Induced Bladder and Bowel Cancer Risks after Conventionally and Hypo-Fractionated Radiotherapy for the Preoperative Management of Rectal Carcinoma.Journal of personalized medicine · 2022Article
- VMAT for prostate cancer with 6-MV and 10-MV photons: Impact of beam energy on treatment plan quality and model-based secondary cancer risk estimates.Molecular and clinical oncology · 2021Article
- Evaluation of mixed energy partial arcs for volumetric modulated arc therapy for prostate cancer.Journal of applied clinical medical physics · 2019Article
- Energy-dependent OAR sparing and dose conformity for total marrow irradiation of obese patients.Journal of applied clinical medical physics · 2018Article
- Adjustment of multi-leaf collimator parameters in 4-MV and 6-MV IMRT: A study of veterinary clinical cases.Open veterinary journalArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe purpose of the study was to analyse the dosimetric differences when using 10 MV instead of 6 MV for VMAT treatment plans for post-prostatectomy irradiation of the prostate bed. METHODS AND MATERIALS: Ten post-prostatectomy prostate bed irradiation cases previously treated using 6 MV with volumetric modulated arc therapy (VMAT) were re-planned using 10 MV with VMAT. Prescription dose was 66.6 Gy with 1.8 Gy per fraction for 37 daily fractions. The same structure set, number of arcs, field sizes, and minimum dose to the Planning Target Volume (PTV) were used for both 6 MV and 10 MV plans. Results were collected for dose to Organs at Risk (OAR) constraints, dose to the target structures, number of monitor units for each arc, Body V5, Conformity Index, and Integral Dose. The mean values were used to compare the 6 MV and 10 MV results. To determine the statistical significance of the results, a paired Student t test and power analysis was performed.
resultsStatistically significant lower mean values were observed for the OAR dose constraints for the rectum, bladder-Clinical Target Volume (bladder-CTV), left femoral head, and right femoral head. Also, statistically significant lower mean values were observed for the Body V5, Conformity Index, and Integral Dose.
conclusionsSeveral dosimetric benefits were observed when using 10 MV instead of 6 MV for VMAT based treatment plans. Benefits include sparing more dose from the OAR while still maintaining the same dose coverage to the PTV. Other benefits include lower Body V 5,Conformity Index, and Integral Dose.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.